EVC expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.670800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.585800E-01
Normal-vs-Stage2
4.971000E-01
Normal-vs-Stage3
5.490600E-01
Normal-vs-Stage4
6.688000E-01
Stage1-vs-Stage2
5.478400E-01
Stage1-vs-Stage3
9.496200E-01
Stage1-vs-Stage4
1.662840E-01
Stage2-vs-Stage3
6.807000E-01
Stage2-vs-Stage4
6.752500E-02
Stage3-vs-Stage4
3.162200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.073200E-01
Normal-vs-AfricanAmerican
9.779000E-01
Normal-vs-Asian
6.677600E-01
Caucasian-vs-AfricanAmerican
2.229400E-01
Caucasian-vs-Asian
7.203000E-01
AfricanAmerican-vs-Asian
5.196200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.458800E-01
Normal-vs-Female
5.183000E-01
Male-vs-Female
4.676000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.155400E-01
Normal-vs-Age(41-60Yrs)
5.856200E-01
Normal-vs-Age(61-80Yrs)
4.624000E-01
Normal-vs-Age(81-100Yrs)
3.140200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.496200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.753800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.763000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.548600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.486400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.657400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.933150E-01
Normal-vs-Daily Drinker
1.207790E-01
Normal-vs-Weekly Drinker
9.217800E-01
Normal-vs-Occasional Drinker
2.728000E-01
Normal-vs-Social Drinker
9.030600E-01
Non Drinker-vs-Daily Drinker
6.976000E-01
Non Drinker-vs-Weekly Drinker
1.880240E-02
Non Drinker-vs-Occasional Drinker
9.607800E-01
Non Drinker-vs-Social Drinker
1.314040E-01
Daily Drinker-vs-Weekly Drinker
2.924400E-02
Daily Drinker-vs-Occasional Drinker
7.854800E-01
Daily Drinker-vs-Social Drinker
8.712200E-02
Weekly Drinker-vs-Occasional Drinker
5.186500E-02
Weekly Drinker-vs-Social Drinker
7.057600E-01
Occasional Drinker-vs-Social Drinker
1.410780E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.157200E-01
Normal-vs-Grade 2
1.686550E-01
Normal-vs-Grade 3
2.717000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.565610E-02
Grade 1-vs-Grade 3
6.545900E-02
Grade 1-vs-Grade 4
5.157200E-01
Grade 2-vs-Grade 3
9.324400E-01
Grade 2-vs-Grade 4
1.686550E-01
Grade 3-vs-Grade 4
2.717000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.664200E-01
Normal-vs-NonDiabetic
3.384200E-01
Diabetic-vs-NonDiabetic
6.700400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.947800E-01
Normal-vs-NoPancreatitis
4.129800E-01
Pancreatitis-vs-NoPancreatitis
7.350600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.774000E-01
Normal-vs-N1
5.437600E-01
N0-vs-N1
1.850400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.088400E-01
Normal-vs-TP53-NonMutant
4.892400E-01
TP53-Mutant-vs-TP53-NonMutant
6.596000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
